| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |